Search Details

Word: mergers (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

Kirby ousts Dean of the College Harry R. Lewis ’68. Lewis’ removal is part of a planned merger of the positions of dean of the College and dean of undergraduate education. Shortly after this announcement, Kirby offers the new deanship to then-Dean of Undergraduate Education Benedict H. Gross...

Author: By Zachary Z Norman, CRIMSON STAFF WRITER | Title: Looking Back Through The Years: The Class of 2004's Time at Harvard | 6/10/2004 | See Source »

...MERGER MASTER?...

Author: By Stephen M. Marks, CRIMSON STAFF WRITER | Title: Philanthropist Makes Fortune on ‘Rollup’ Concept | 6/9/2004 | See Source »

...rest is history—and history well-chronicled in the pages of business journals. His success led the Washington Post to nickname him “merger master,” and even Ledecky confirms he had the Midas’ touch...

Author: By Stephen M. Marks, CRIMSON STAFF WRITER | Title: Philanthropist Makes Fortune on ‘Rollup’ Concept | 6/9/2004 | See Source »

...Elsewhere in the two-and-a-half-hour presentation (yes, two and a half hours - the network's strategy is to sell ads through exhaustion) NBC crowed about its recent merger with Universal, home of a movie studio and cable channels from Bravo to Telemundo. "Imagine... two media powers, visionaries from the start..." intoned Katie Couric in a dead-serious filmed intro, as she, Sean Hayes, Jay Leno and Jesse L. Martin tried to convince advertisers of the synergistic possibilities of having Donald Trump and the guy who yells "gooooooooooooooooooal!" during Spanish-language soccer broadcasts under one corporate roof...

Author: /time Magazine | Title: NBC: Nothin' But Conventional | 5/18/2004 | See Source »

...hostile bid for the Strasbourg-based Aventis--to create a French "national champion" in the pill market--and why the government warned Swiss drugmaker Novartis to stop fishing in the Rhine. Sanofi-Aventis will be the world's third largest pharmaceutical firm, after Pfizer and GlaxoSmithKline. But since the merger announcement, Sanofi's shares have tumbled, in part because investors think $66 billion is too high a price for Aventis, whose big moneymaker, the allergy medicine Allegra, not only competes with Claritin, which is sold over the counter in the U.S., but will soon also square off against several generic...

Author: /time Magazine | Title: World Briefing: May 17, 2004 | 5/17/2004 | See Source »

Previous | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | Next